Trial intelligence / Profile preview

N-acetylcysteine for Common Cold Associated with Cough

NCT02379637Phase 2Completed

Sponsor
Novartis
Start
Jan 2015
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in common cold, sponsored by Novartis. Started Jan 2015; status: completed.

02

Drugs

acetylcysteine
03

Conditions

common cold

Beyond the preview

Go deeper on NCT02379637.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02379637.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call